Columvi® (Glofitamab for Injection) Receives Positive CADTH and INESSS Recommendations for Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
The process for Canadians to access new medicines is complex and involves several different federal, provincial, and territorial agencies. As Roche Canada, we stand ready to work collaboratively to bring… Read More




